VRTX: Upcoming renal and pain catalysts, IgAN launch, and pipeline expansion drive growth outlook
Multiple near-term catalysts include pivotal renal and pain data, a major IgAN launch, and expanded commercial focus following the Crinetics acquisition. Strategic priorities center on broadening the pipeline, accelerating launches, and building a diversified revenue base across five disease pillar…
Multiple near-term catalysts include pivotal renal and pain data, a major IgAN launch, and expanded commercial focus following the Crinetics acquisition. Strategic priorities center on broadening the pipeline, accelerating launches, and building a diversified revenue base across five disease pillar…